Magnetic Resonance plaque imaging before Carotid Artery Stenting (MR-CAS) trial

Magnetic Resonance plaque imaging before Carotid Artery Stenting (MR-CAS) trial - Magnetic Resonance plaque imaging before Carotid Artery Stenting (MR-CAS) trial

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000009205

Enrollment

200

Registered

2012-11-01

Start date

2011-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

carotid artery stenosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patient scheduled for CAS from Oct. 1st, 2011 to Sept. 30th, 2013 2) Patients can receive MR plaque imaging before CAS 3) Patient who signed an informed consent form

Exclusion criteria

Exclusion criteria: Patients who are judged as inappropriate to participate in this study

Design outcomes

Primary

Measure	Time frame
Major adverse event (MAE) including any stroke, myocardial infarction, or death within 90 (+/-10) days after CAS	—

Secondary

Measure	Time frame
1) Relationship between MR plaque imaging and MAEs or the number of newly appeared high intensity signals 1-3 days after CAS 2) Relationship between method of cerebral protection and MAEs or the number of newly appeared high intensity signals 1-3 days after CAS 3) Relationship between laboratory data and MAEs or the number of newly appeared high intensity signals 1-3 days after CAS 4) Relationship between stent type and MAEs or the number of newly appeared high intensity signals 1-3 days after CAS	—

Measure

Time frame

1) Relationship between MR plaque imaging and MAEs or the number of newly appeared high intensity signals 1-3 days after CAS 2) Relationship between method of cerebral protection and MAEs or the number of newly appeared high intensity signals 1-3 days after CAS 3) Relationship between laboratory data and MAEs or the number of newly appeared high intensity signals 1-3 days after CAS 4) Relationship between stent type and MAEs or the number of newly appeared high intensity signals 1-3 days after CAS

—

Countries

Japan

Outcome results